2026 Q2 - tulosraportti
Vain PDF
54 päivää sitten
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 169 | - | - | ||
| 1 700 | - | - | ||
| 1 001 | - | - | ||
| 10 | - | - | ||
| 1 000 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastot ja ETF:t, joilla on osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 - tulosraportti 29.10. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 - tulosraportti 20.8. | ||
2026 Q1 - tulosraportti 7.5. | ||
2025 Q4 - tulosraportti 26.2. | ||
2025 Q3 - tulosraportti 22.10.2025 | ||
2025 Q2 - tulosraportti 21.8.2025 |
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
·9 t sittenIt is uncertain whether the decree in France will be signed, the only thing I can figure out is that it turns out there is political resistance. I cannot find any details as to why. The interest organizations cannot find them either. That is the latest news from France that I have been able to dig up
·12 t sittenI would like to hear your opinion about the company and the industry and not how much is being sold at a pharmacy. Are there any bids on that?
It might take several years, but my case for stenocare is that revenue in the long run will increase a lot from current level, as Astrum 10-10 seems to be the best oil on the market. 2,3x higher bioavailability than standard oils. Faster and more stable effect regardless of food intake. And it is actually cheaper for the user/insurance in the long run. 1 dose is generally more expensive than the competitors but since you don't need to use the same amount of oil to achieve the desired effect the bottles last longer.- ·3 päivää sittenStock Status It is sold out in pharmacies in Bad Wörishofen It is continuously sold out in the various pharmacies in Germany.. This is a sign that doctors are prescribing Weeco Astrum 10/10.
- ·8.10.stock status Weed.de: 2 pharmacies have received Weeco Astrum back in stock Flowzs; 1 pharmacy has received Weeco Astrum back in stock. Private prescription: 1 pharmacy has received Weeco Astrum back in stock. It is just a matter of time before all pharmacies that had the oil in stock before July 30 have received Weeco Astrum back in stock.
- ·8.10.Medicinal cannabis is here to stay, because it is also a major economic advantage for society. I have been thinking. When medicinal cannabis can replace medicine with serious side effects, then there must also be an economic gain for society, and therefore I have been thinking about whether there have been any studies regarding this subject. There have been in England. A research group from the University of York in England has published their results. What they have found out is that medicinal cannabis actually saves society a full 729 £ (6500 dkk) per patient per year. Nothing has been published by Danish researchers yet, but I am sure they will arrive at roughly the same result. I have inserted two links. The top one is a link to a research study about savings. The second link is a study where 2,897 patients who have been on opioids and replaced this with medicinal cannabis. One of the answers was; when the researchers asked about the effect, 81 % of the patients reported that it was more effective to take medicinal cannabis alone to treat their pain condition Medicinal cannabis can save the NHS 4 billion pounds each year (equivalent to the public hospital system and the regions in Denmark). https://www.cicouncil.org.uk/medical-cannabis-could-save-nhs-4-billion-each-year/ Cannabis as a replacement for opioid-based painkillers: Patients' self-report https://pmc.ncbi.nlm.nih.gov/articles/PMC5569620/Personal. So I am waiting but very impatient and in doubt whether management actually manages to meet their own goals.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tuotteita joiden kohde-etuutena tämä arvopaperi
Välittäjätilasto
Dataa ei löytynyt
2026 Q2 - tulosraportti
Vain PDF
54 päivää sitten
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
- ·9 t sittenIt is uncertain whether the decree in France will be signed, the only thing I can figure out is that it turns out there is political resistance. I cannot find any details as to why. The interest organizations cannot find them either. That is the latest news from France that I have been able to dig up
- ·12 t sittenI would like to hear your opinion about the company and the industry and not how much is being sold at a pharmacy. Are there any bids on that?It might take several years, but my case for stenocare is that revenue in the long run will increase a lot from current level, as Astrum 10-10 seems to be the best oil on the market. 2,3x higher bioavailability than standard oils. Faster and more stable effect regardless of food intake. And it is actually cheaper for the user/insurance in the long run. 1 dose is generally more expensive than the competitors but since you don't need to use the same amount of oil to achieve the desired effect the bottles last longer.
- ·3 päivää sittenStock Status It is sold out in pharmacies in Bad Wörishofen It is continuously sold out in the various pharmacies in Germany.. This is a sign that doctors are prescribing Weeco Astrum 10/10.
- ·8.10.stock status Weed.de: 2 pharmacies have received Weeco Astrum back in stock Flowzs; 1 pharmacy has received Weeco Astrum back in stock. Private prescription: 1 pharmacy has received Weeco Astrum back in stock. It is just a matter of time before all pharmacies that had the oil in stock before July 30 have received Weeco Astrum back in stock.
- ·8.10.Medicinal cannabis is here to stay, because it is also a major economic advantage for society. I have been thinking. When medicinal cannabis can replace medicine with serious side effects, then there must also be an economic gain for society, and therefore I have been thinking about whether there have been any studies regarding this subject. There have been in England. A research group from the University of York in England has published their results. What they have found out is that medicinal cannabis actually saves society a full 729 £ (6500 dkk) per patient per year. Nothing has been published by Danish researchers yet, but I am sure they will arrive at roughly the same result. I have inserted two links. The top one is a link to a research study about savings. The second link is a study where 2,897 patients who have been on opioids and replaced this with medicinal cannabis. One of the answers was; when the researchers asked about the effect, 81 % of the patients reported that it was more effective to take medicinal cannabis alone to treat their pain condition Medicinal cannabis can save the NHS 4 billion pounds each year (equivalent to the public hospital system and the regions in Denmark). https://www.cicouncil.org.uk/medical-cannabis-could-save-nhs-4-billion-each-year/ Cannabis as a replacement for opioid-based painkillers: Patients' self-report https://pmc.ncbi.nlm.nih.gov/articles/PMC5569620/Personal. So I am waiting but very impatient and in doubt whether management actually manages to meet their own goals.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 169 | - | - | ||
| 1 700 | - | - | ||
| 1 001 | - | - | ||
| 10 | - | - | ||
| 1 000 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastot ja ETF:t, joilla on osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 - tulosraportti 29.10. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 - tulosraportti 20.8. | ||
2026 Q1 - tulosraportti 7.5. | ||
2025 Q4 - tulosraportti 26.2. | ||
2025 Q3 - tulosraportti 22.10.2025 | ||
2025 Q2 - tulosraportti 21.8.2025 |
Tuotteita joiden kohde-etuutena tämä arvopaperi
Välittäjätilasto
Dataa ei löytynyt
2026 Q2 - tulosraportti
Vain PDF
54 päivää sitten
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 - tulosraportti 29.10. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 - tulosraportti 20.8. | ||
2026 Q1 - tulosraportti 7.5. | ||
2025 Q4 - tulosraportti 26.2. | ||
2025 Q3 - tulosraportti 22.10.2025 | ||
2025 Q2 - tulosraportti 21.8.2025 |
Tuotteita joiden kohde-etuutena tämä arvopaperi
Foorumi
Liity keskusteluun Nordnet Socialissa
- ·9 t sittenIt is uncertain whether the decree in France will be signed, the only thing I can figure out is that it turns out there is political resistance. I cannot find any details as to why. The interest organizations cannot find them either. That is the latest news from France that I have been able to dig up
- ·12 t sittenI would like to hear your opinion about the company and the industry and not how much is being sold at a pharmacy. Are there any bids on that?It might take several years, but my case for stenocare is that revenue in the long run will increase a lot from current level, as Astrum 10-10 seems to be the best oil on the market. 2,3x higher bioavailability than standard oils. Faster and more stable effect regardless of food intake. And it is actually cheaper for the user/insurance in the long run. 1 dose is generally more expensive than the competitors but since you don't need to use the same amount of oil to achieve the desired effect the bottles last longer.
- ·3 päivää sittenStock Status It is sold out in pharmacies in Bad Wörishofen It is continuously sold out in the various pharmacies in Germany.. This is a sign that doctors are prescribing Weeco Astrum 10/10.
- ·8.10.stock status Weed.de: 2 pharmacies have received Weeco Astrum back in stock Flowzs; 1 pharmacy has received Weeco Astrum back in stock. Private prescription: 1 pharmacy has received Weeco Astrum back in stock. It is just a matter of time before all pharmacies that had the oil in stock before July 30 have received Weeco Astrum back in stock.
- ·8.10.Medicinal cannabis is here to stay, because it is also a major economic advantage for society. I have been thinking. When medicinal cannabis can replace medicine with serious side effects, then there must also be an economic gain for society, and therefore I have been thinking about whether there have been any studies regarding this subject. There have been in England. A research group from the University of York in England has published their results. What they have found out is that medicinal cannabis actually saves society a full 729 £ (6500 dkk) per patient per year. Nothing has been published by Danish researchers yet, but I am sure they will arrive at roughly the same result. I have inserted two links. The top one is a link to a research study about savings. The second link is a study where 2,897 patients who have been on opioids and replaced this with medicinal cannabis. One of the answers was; when the researchers asked about the effect, 81 % of the patients reported that it was more effective to take medicinal cannabis alone to treat their pain condition Medicinal cannabis can save the NHS 4 billion pounds each year (equivalent to the public hospital system and the regions in Denmark). https://www.cicouncil.org.uk/medical-cannabis-could-save-nhs-4-billion-each-year/ Cannabis as a replacement for opioid-based painkillers: Patients' self-report https://pmc.ncbi.nlm.nih.gov/articles/PMC5569620/Personal. So I am waiting but very impatient and in doubt whether management actually manages to meet their own goals.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 169 | - | - | ||
| 1 700 | - | - | ||
| 1 001 | - | - | ||
| 10 | - | - | ||
| 1 000 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastot ja ETF:t, joilla on osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Välittäjätilasto
Dataa ei löytynyt